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TheNMR structures ofCorynebacterium glutamicumOdhI described by Barthe et al. in this issue ofStructure
reveal a major conformational rearrangement upon phosphorylation, suggesting an autoinhibition mecha-
nism that accounts for the functional properties of the protein as a regulatory switch in glutamatemetabolism.Reversible protein phosphorylation is
probably the major mechanism of cell
signaling in living cells. The formation
and dissociation of protein complexes,
driven by the recognition of phospho-
dependent interaction sites, allow the
dynamic establishment of a myriad of
different signal transduction pathways.
While protein kinases and phosphatases
are natural players in these processes,
signal transduction would be impossible
without the protein modules that are
able to specifically bind phosphorylated
residues on target proteins (Seet et al.,
2006). A classic example is the SH2 (Src
Homology 2) domain, considered as the
prototype of signaling module specific
for phosphotyrosine. Concerning the
even more widespread Ser/Thr phosphor-
ylation, a close functional homolog of the
SH2 domain is the ForkHead-Associated
(FHA) domain (Hofmann and Bucher,
1995), which specifically binds phospho-
threonine (pThr) residues and participates
in diverse biological functions (for a recent
review, see Mahajan et al. [2008]).
Overwhelming evidence has accumu-
lated in the last few years about the phys-
iological role of Ser/Thr phosphorylation,
not only in eukaryotes but also in bacterial
signaling processes. A clear illustration is
the recent discovery that the tricarboxylic
acid (TCA) cycle in C. glutamicum is post-
transcriptionally regulated by the Ser/Thr
protein kinase PknG through its target
protein OdhI, composed of a single FHA
domain with a N-terminal extension that
includes the kinase substrate motif (Nie-
bisch et al., 2006). The unphosphorylated
form of OdhI binds to and inhibits OdhA,
the E1 subunit of the a-ketoglutarate
complex (ODH), whereas the PknG phos-
phorylation of OdhI relieves this inhibition
(Bott, 2007; Niebisch et al., 2006). A
similar control mechanism was also found
to be operational in mycobacteria, whereGarA (the OdhI homolog) inhibits not
only the a-ketoglutarate decarboxylase
(KGD, the OdhA homolog) but also a large
NAD+-specific glutamate dehydrogenase
(GDH) (O’Hare et al., 2008). As in C. gluta-
micum, phosphorylation of GarA by PknG
(or PknB, another conserved Ser/Thr
protein kinase [Villarino et al., 2005})
relieves the inhibition. The two metabolic
enzymes, KGD and GDH, share a-keto-
glutarate as the common substrate and
lie at a fundamental branching point for
nitrogen metabolism; a-ketoglutarate
can be either oxidized by KGD to succinic
semialdehyde and re-enter the Krebs
cycle in the form of succinate through
the concerted action of succinic semial-
dehyde dehydrogenase, or be converted
to glutamate by GDH and eventually to
glutamine by the action of glutamine
synthetase. GarA would thus act as the
regulatory switch between the two path-
ways, redirecting the flux of a-ketogluta-
rate toward the production of glutamate
when unphosphorylated (O’Hare et al.,
2008).
In this issue of Structure, Barthe et al.
(2009) report the NMR structure of
C. glutamicum OdhI in both the unphos-
phorylated and phosphorylated forms.
The structure of unphosphorylated OdhI
reveals the canonical 11-strands b sand-
wich core of the FHA domain, while the
N-terminal extension of the protein
(including the phosphorylatable Thr re-
sidue) is fully disordered. The phosphory-
lation of Thr15 promotes binding in cis
of the pThr to the FHA domain, inducing
the partial folding of the N-terminal exten-
sion and preventing any further interaction
of the FHA with other (phospho) proteins.
As observed in previous structures of
FHA-phosphopeptide complexes, seven
residues (centered around pThr15) are in
contact with the FHA core domain, while
part of the connecting peptide (residuesStructure 17, April 15, 200920-29) fold into an amphipatic a helix that
makes hydrophobic contacts with the
external face of FHA strands b7-b8, rein-
forcing the intramolecular interaction
(Barthe et al., 2009). These findings sug-
gest a novel mechanism of autoin-
hibition of OdhI/GarA in response to
phosphorylation and suggest a model in
which these small FHA proteins operate
as molecular switches acting at a crucial
‘‘checkpoint’’ of glutamate metabolism in
actinobacteria. Phosphorylation would
be the signal triggering the switch from
the ‘‘on’’ state (interacting) to the ‘‘off’’
state, characterized by the intramolecular
closure of the FHA domain (Barthe et al.,
2009). This model is fully consistent with
the recent biophysical studies of myco-
bacterial GarA, which demonstrate that
phosphorylation significantly increases
the thermal stability of the protein as
a result of the tight interaction between
the FHA domain and the phosphorylated
N-terminal peptide (England et al., 2009).
OdhI and GarA are both specifically
phosphorylated on a single Thr residue
in a highly conserved ETTS motif. How-
ever, phosphorylation is site-specific and
dependent on the kinase, since PknG
was shown to phosphorylate the first of
the two adjacent Thr residues (Niebisch
et al., 2006; O’Hare et al., 2008) and
PknB the second (Barthe et al., 2009;
Villarino et al., 2005). The OdhI structure
suggests that phosphorylation at Thr14
would promote a conformational rear-
rangement similar to that observed upon
phosphorylation at Thr15, facilitated by
the flexibility of the N-terminal region con-
necting the ETTS motif to the FHA domain
(Barthe et al., 2009). This is in agreement
with the observation that phosphorylation
of the mycobacterial homolog at either of
the equivalent threonine (Thr21 or Thr22)
induces a comparable increase in thermal
stability (England et al., 2009). Takenª2009 Elsevier Ltd All rights reserved 487
Structure
Previewstogether, these observations strongly
suggest that the inhibitory properties of
the regulator can be turned off in a similar
way by different kinases transferring the
phosphate group to adjacent Thr resi-
dues.
This form of control of a major meta-
bolic intermediate through the direct inhi-
bition of different enzymes represents to
our knowledge a novel function for an
FHA protein, as these pThr-binding
modules are usually considered as scaf-
folds that promote the interaction of
signaling partners in response to phos-
phorylation. It remains to be determined
whether the interaction of OdhI/GarA
with the regulated enzymes depends on
the FHA domain (which would likely
recognize a putative phosphorylation site
in the target enzyme) or on the N-terminal
extension carrying the phosphorylatable
threonine. The first hypothesis would not
only imply a double control by Thr phos-488 Structure 17, April 15, 2009 ª2009 Elsevphorylation (at the target enzyme to
create the OdhI/GarA binding site, and
at the regulatory protein itself to switch
off inhibition), but also suggests that
OdhI/GarA might bind to and regulate
additional phosphoprotein targets (in
fact, GarA was initially characterized as
a regulator of glycogen accumulation in
Mycobacterium smegmatis [Belanger
and Hatfull, 1999]). Further research
work is certainly desirable to understand
the interactions of OdhI/GarA with its
enzyme target(s) as well as to ascertain
whether this FHA protein is indeed
a common regulator of different metabolic
pathways in actinobacteria.REFERENCES
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